Compare eBay Inc (EBAY) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
eBay Inc vs Inovio Pharmaceuticals Inc — how do they compare? eBay Inc trades at $102.8 (market cap $47.17B), while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M). The key difference: eBay Inc is far larger — about 600.5× Inovio Pharmaceuticals Inc's market cap, and eBay Inc pays a 1.17% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| EBAY | INO | |
|---|---|---|
Market Cap | $47.17B | $78.55M |
Volume | 5,186,418 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $118.96 | $2.87 |
52-Week Low | $79.41 | $0.66 |
Enterprise Value | $51.00B | $49.56M |
Dividend Yield | 1.17% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EBAY stock trades at $102.62, down 4.73% on news that GameStop may abandon its $56 billion takeover bid in favor of a partnership. The stock exhibits a bearish technical signal with key support at $104, while fundamentals show strong profitability with an 18.57% net income margin and consistent earnings beats in recent quarters. Revenue growth is projected to reach $12.0 billion in 2026, though cash flow turned negative in 2025.
The outlook is mixed: analyst consensus targets $119.31 with 46% buy ratings, but near-term sentiment is pressured by takeover uncertainty. Risks include competitive threats in e-commerce and reliance on focus categories. Upside hinges on execution of live shopping initiatives and potential partnership benefits.
INO trades at $0.76, up 2.74% today, but remains in a bearish technical trend. The company shows minimal revenue of $65K against high operating losses, with a net income margin of -130,000%. Recent quarterly EPS has beaten expectations. Analyst consensus is bullish with a $3.25 price target, but the stock faces significant fundamental challenges including negative cash flow and high valuation multiples.
The outlook hinges on FDA approval of INO-3107 in October 2026, a binary event that could drive substantial upside. However, persistent cash burn, negative profitability, and ongoing shareholder litigation present high risks. Investors should weigh the potential catalyst against the company's weak financial health and operational execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About eBay Inc
eBay Inc. is a global commerce company. The Company's platforms are designed to enable sellers worldwide to organize and offer their inventory for sale and buyers to find and buy it. eBay's items can be new or used, plain or luxurious, commonplace or rare, trendy or one-of-a-kind.
Read more on EBAY →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
